Wataru Sakamoto
- Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusionBy Keiji Oishi, Keisuke Aoe, Yoriyuki Murata, Kenji Sakamoto, Takashi Ohfuji, Wataru Kotoku, Yoshiko Ogata, Tsuneo Matsumoto, Hiroshi Ueoka and Yusuke MimuraKeiji Oishi1Respiratory Medicine, NHO Yamaguchi-Ube Medical Center, Ube, Japan2Clinical Research, NHO Yamaguchi-Ube Medical Center, Ube, JapanKeisuke Aoe1Respiratory Medicine, NHO Yamaguchi-Ube Medical Center, Ube, Japan2Clinical Research, NHO Yamaguchi-Ube Medical Center, Ube, JapanYoriyuki Murata1Respiratory Medicine, NHO Yamaguchi-Ube Medical Center, Ube, Japan2Clinical Research, NHO Yamaguchi-Ube Medical Center, Ube, JapanKenji Sakamoto1Respiratory Medicine, NHO Yamaguchi-Ube Medical Center, Ube, JapanTakashi Ohfuji1Respiratory Medicine, NHO Yamaguchi-Ube Medical Center, Ube, JapanWataru Kotoku1Respiratory Medicine, NHO Yamaguchi-Ube Medical Center, Ube, JapanYoshiko Ogata1Respiratory Medicine, NHO Yamaguchi-Ube Medical Center, Ube, JapanTsuneo Matsumoto1Respiratory Medicine, NHO Yamaguchi-Ube Medical Center, Ube, JapanHiroshi Ueoka1Respiratory Medicine, NHO Yamaguchi-Ube Medical Center, Ube, JapanYusuke Mimura2Clinical Research, NHO Yamaguchi-Ube Medical Center, Ube, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaArticle | Published in 2014 in European Respiratory JournalTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaArticle | Published in 2014 in European Respiratory JournalTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.